Evaluation of etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazole

Journal of Clinical Microbiology

Volumn 45, Issue 6, 2007, Pages 1974-1977

  Diekema, Daniel J ^a   Messer, Shawn A ^a   Hollis, Richard J ^a   Boyken, Linda B ^a   Tendolkar, Shailesh ^a   Kroeger, Jennifer ^a   Pfaller, Michael A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; POSACONAZOLE;

AGAR GEL DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGAR; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CULTURE MEDIA; DISK DIFFUSION ANTIMICROBIAL TESTS; HUMANS; MICROBIAL SENSITIVITY TESTS; TRIAZOLES;

CANDIDA;

EID: 34250633596     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02087-06     Document Type: Article

References (9)

1. Barry, A. L., M. A. Pfaller, S. D. Brown, et al. 2000. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J. Clin. Microbiol. 38:3457-3459.
2. Clinical and Laboratory Standards Institute. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard, 2nd ed., M27-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Clinical and Laboratory Standards Institute. 2004. Method for antifungal disk diffusion susceptibility testing of yeasts: approved guidance M44-A. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Espinel-Ingroff, A., and A. Rezusta. 2002. Etest method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method. J. Clin. Microbiol. 40:2101-2107.
5. Pfaller, M. A., D. J. Diekema, L. Boyken, et al. 2003. Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole. J. Clin. Microbiol. 41:1875-1880.
6. Pfaller, M. A., S. A. Messer, K. Mills, et al. 2001. 2001. Evaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida species. J. Clin. Microbiol. 39:3952-3954.
7. Pfaller, M. A., D. Diekema, S. Messer, L. Boyken, and R. Hollis. 2003. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J. Clin. Microbiol. 41:1440-1446.
8. Pfaller, M. A., D. J. Diekema, M. G. Rinaldi, et al. 2005. Results from the ARTEMIS DISK Global Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J. Clin. Microbiol. 43:5848-5859.
9. Sims, C. R., V. L. Paetznick, J. R. Rodriguez, et al. 2006. Correlation between microdilution, Etest, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp. J. Clin. Microbiol. 44:2105-2108.